glp receptor - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC4216654/ Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists - PMC Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial... glp receptor cardiovascular effects glucagon like https://adisinsight.springer.com/drugsafety/803923427?error=cookies_not_supported&code=a3519a44-3bcc-4992-9dfd-48a257c62be3 GLP-1 receptor agonist-related psychiatric AEs - AdisInsight Use of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide for weight loss may cause psychiatric adverse events (AEs), according to findings of a glp receptor agonist related psychiatric https://pubmed.ncbi.nlm.nih.gov/32700772/ GLP-1 receptor agonists for Parkinson's disease Low- or very low-certainty evidence suggests that exenatide may improve motor impairment for people with PD. The difference in motor impairment observed... glp receptor agonists parkinson disease https://pmc.ncbi.nlm.nih.gov/articles/PMC6928920/ Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm... Diabetic nephropathy (DN) is one of the most perilous side effects of diabetes mellitus type 1 and type 2 (T1DM and T2DM).). It is known that sodium/glucose... https://pubmed.ncbi.nlm.nih.gov/40788647/ GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2... In this cohort study of individuals with T2D, GLP-1 RA use was associated with a modestly increased risk of incident DR; however, fewer patients experienced... https://pubmed.ncbi.nlm.nih.gov/39002641/ Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized,... https://pubmed.ncbi.nlm.nih.gov/38799233/ GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation Atrial fibrillation (AF) is the most common cardiac arrhythmia. Many medical conditions, including hypertension, diabetes, obesity, sleep apnea, and heart... glp receptor agonists metabolism fibrillation https://pubmed.ncbi.nlm.nih.gov/40854315/ Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in... Hangzhou Sciwind Biosciences. efficacy and safety https://pmc.ncbi.nlm.nih.gov/articles/PMC12656553/ Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary... Semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist, is widely prescribed for weight loss in non-diabetic populations. Given the link between... https://pmc.ncbi.nlm.nih.gov/articles/PMC12516549/ Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut... As a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, Tirzepatide (TZP) is a recently... https://pmc.ncbi.nlm.nih.gov/articles/PMC11840199/ Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based... Obesity is a global epidemic. The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric... https://events.diabetes.org/p/s/weighing-the-use-of-glp-1-receptor-agonists-prior-to-pregnancy-5533 Weighing the Use of GLP-1 Receptor Agonists prior to Pregnancy - American Diabetes Association https://pmc.ncbi.nlm.nih.gov/articles/PMC12528064/ GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain in Severe and... Patients with severe and persistent mental illness (SPMI) experience significant metabolic side effects from antipsychotic medications, including... https://catalogues.ema.europa.eu/node/3953/administrative-details Association between exposure to GLP-1 receptor agonists and risk of suicide-related and... https://pmc.ncbi.nlm.nih.gov/articles/PMC11206448/ Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the... Currently, there is no known cure for diabetes. Different pharmaceutical therapies have been approved for the management of type 2 diabetes mellitus (T2DM),... https://researchconnect.buffalo.edu/en/publications/simultaneous-glp-1-receptor-activation-and-angiotensin-receptor-b/ Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis... simultaneous glp receptor activation angiotensin https://pmc.ncbi.nlm.nih.gov/articles/PMC12702299/ Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and... To quantify the extent of metabolic and cardiovascular rebound following the discontinuation of GLP-1 receptor agonist (GLP-1RA) therapy in adults with... https://www.ncbi.nlm.nih.gov/Structure/pdb/7DUQ 7DUQ: Cryo-EM structure of the compound 2 and GLP-1-bound human GLP-1 receptor-Gs complex Glucagon-like peptide 1Glucagon-like peptide 1 receptorGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Guanine nucleotide-binding protein... https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289616 The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population... Aim To uncover the effect of GLP-1 receptor agonists (GLP-1 RAs) on the visceral- and hepatic fat content of adults. Methods PubMed, EMBASE, Cochrane Library,... https://pmc.ncbi.nlm.nih.gov/articles/PMC11063291/ GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case... Lymphedema is a major public health issue for many women undergoing breast cancer treatment. Although weight loss has been reported to be beneficial in the... https://pubchem.ncbi.nlm.nih.gov/bioassay/624418 AID 624418 - qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen - PubChem BioAssay record AID 624418 submitted by National Center for Advancing Translational Sciences (NCATS): qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. https://pubmed.ncbi.nlm.nih.gov/40807170/ SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review Sodium-glucose co-transporter-2 inhibitors (SGLT2is) and GLP-1 receptor agonists (GLP-1 RAs) are now established as cornerstone therapies for patients with... https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1431292/full Frontiers | Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor... Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are two incretins that bind to their respective receptors and activate... mechanisms of action therapeutic applications https://events.diabetes.org/p/s/risk-of-neovascular-amd-among-diabetic-patients-using-glp-1-receptor-agonists-5077 Risk of Neovascular AMD among Diabetic Patients Using GLP-1 Receptor Agonists - American Diabetes... https://events.diabetes.org/p/s/glp-1-receptor-agonists-2531 GLP-1 Receptor Agonists - American Diabetes Association american diabetes glp receptor agonists association https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/Are-patient-factors-associated-with-adverse/991022170557104721?institution=01DRXU_INST&skipUsageReporting=true&recordUsage=false Are patient factors associated with adverse perioperative outcomes in GLP-1 receptor agonist users?... Background: Use of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) is increasing. Perioperative GLP-1RA continuation has adverse and beneficial effects.... https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-reports-of-diabetic-ketoacidosis-when-concomitant-insulin-was-rapidly-reduced-or-discontinued?UNLID=803528536202429105635&UNLID=305510885202641815649 GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly... Diabetic ketoacidosis has been reported in patients with type 2 diabetes on a combination of a GLP-1 receptor agonist and insulin who had doses of concomitant... https://events.diabetes.org/p/s/achieve-ing-goals-where-do-nonpeptide-oral-glp-1-receptor-agonists-fit-in-the-treatment-algorithm-5592 ACHIEVE-ing Goals: Where Do Nonpeptide Oral GLP-1 Receptor Agonists Fit in the Treatment Algorithm?... https://mydss.mo.gov/media/pdf/glucagon-peptide-1-glp-1-receptor-agonists-indicated-obesity-pdl-edit Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Indicated for Obesity PDL Edit | mydss.mo.gov https://anesthesia.uchicago.edu/dr-yuan-senior-author-bmj-review-and-meta-analysis-glp1-agonists Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns |... https://vivo.colorado.edu/display/pubid_392211 Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists | CU Experts | CU Boulder https://pubmed.ncbi.nlm.nih.gov/41331950/ Investigating the association between GLP-1 receptor agonists and mood disorders: A study... Both observational and MR analyses showed that patients treated with GLP-1 RAs may have no increased risk of emotional and behavioral disorders. Instead,... https://pmc.ncbi.nlm.nih.gov/articles/PMC12303005/? The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review... https://pmc.ncbi.nlm.nih.gov/articles/PMC10705578/ Physiology of the Weight Loss Plateau after Calorie Restriction, GLP-1 Receptor Agonism, and... To investigate why different weight loss interventions result in varying durations of weight loss prior to approaching plateaus. A validated mathematical model... https://pmc.ncbi.nlm.nih.gov/articles/PMC8442438/ GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of... A meta-analysis is presented of cardiovascular outcome trials (CVOTs) comparing glucagon-like peptide-1 receptor agonists (GLP-1RA) versus placebo on... https://researchprofiles.ku.dk/da/publications/the-glp-1-receptor-agonist-lixisenatide-reduces-postprandial-gluc/ The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes... https://miriamftps929348.blogdal.com/ copyright and GLP-1 Receptor Agonists : Understanding the Treatments - homepage copyright and GLP-1 Receptor Agonists : Understanding the Treatments - homepage copyright glp receptor agonists understanding https://pubmed.ncbi.nlm.nih.gov/41931049/ GLP-1 Receptor Agonists Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes... glp receptor agonists https://scholars.duke.edu/publication/1706900 Scholars@Duke publication: Abstract B041: GLP-1 receptor agonists associated with improved response... https://prism.northwestern.edu/records/tt7z0-7bx51 A Shot in the Dark: The Paradoxical Effects of GLP-1 Receptor Agonists on Rotator Cuff Disease and... This systematic evidence review evaluates four retrospective cohort studies examining the relationship between Glucagon-Like Peptide-1 receptor agonist (GLP-1... a shot in the dark https://pmc.ncbi.nlm.nih.gov/articles/PMC12898445/ Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity... Orforglipron (LY3502970) is a novel, orally available, nonpeptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) designed to replicate the efficacy of... https://lombardi.georgetown.edu/tag/glp-1-receptor-agonists/ GLP-1 receptor agonists Archives - Lombardi Comprehensive Cancer Center glp receptor agonists archives lombardi https://www.opt.uh.edu/about/college-news-events/articles/seeing-the-bigger-picture-how-glp-1-receptor-agonists-are-shaping-the-future-of-diabetes-and-vision-care.cfm Seeing the Bigger Picture: How GLP-1 Receptor Agonists Are Shaping the Future of Diabetes and... UHCO researcher Kaitlyn Sapoznik investigates how GLP-1 medications used for diabetes and obesity may influence retinal health and future vision care. seeing the bigger picture https://events.diabetes.org/p/s/results-of-first-phase-3-study-of-retatrutide-a-gip-glp-1-and-glucagon-receptor-agonist-in-patients-with-obesity-triumph-1-5581 Results of First Phase 3 Study of Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist in... https://www.cochrane.org/evidence/CD015849_does-treatment-glp-1-receptor-agonists-prevent-complications-people-chronic-kidney-disease-and Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney... https://pmc.ncbi.nlm.nih.gov/articles/PMC9438179/ Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with... Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist approved for the treatment of type 2 diabetes in the USA, Europe, and the UAE. Tirzepatide is an... https://pmc.ncbi.nlm.nih.gov/articles/PMC7910049/ The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in... Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome... https://pmc.ncbi.nlm.nih.gov/articles/PMC12270588/ Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning - PMC Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is... https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00051/full Frontiers | The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material... Type 2 diabetes mellitus (T2DM) has recently been recognized as a significant risk factor for bone fragility. Careful investigations of bone strength in huma... https://pharma.economictimes.indiatimes.com/tag/glp-1+receptor+agonists Glp 1 receptor agonists - Latest glp 1 receptor agonists , Information & Updates - Pharma -ETPharma ETPharma.com brings latest glp 1 receptor agonists news, views and updates from all top sources for the Indian Pharma industry. latest information glp receptor agonists updates https://pubmed.ncbi.nlm.nih.gov/39797880/ Coronary Artery Calcium Scoring Improves Allocation of the GLP-1 Receptor Agonist Semaglutide Coronary Artery Calcium Scoring Improves Allocation of the GLP-1 Receptor Agonist Semaglutide coronary artery calcium https://events.diabetes.org/p/s/muscle-preserving-weight-loss-with-rv-8451-a-novel-oral-nonpeptide-glp-1-receptor-agonist-in-diet-induced-obese-nonhuman-primates-5851 Muscle-Preserving Weight Loss with RV-8451, a Novel, Oral Nonpeptide GLP-1 Receptor Agonist, in... Disclosures - S.COLLADO: Employee; Current; Rivus Pharmaceuticals. O.M.KHAN: None. J.DENNIS: Employee; Current; Rivus Pharmaceuticals, Stock/Shareholder;... https://pmc.ncbi.nlm.nih.gov/articles/PMC12830215/ Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and... Individuals with type 2 diabetes mellitus are treated with a growing variety of medications targeting multiple metabolic pathways. In recent years, incretins... hematologic malignancies https://pubmed.ncbi.nlm.nih.gov/39030327/ Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a... Obesity is a risk factor for developing and worsening multiple sclerosis (MS) and is often comorbid with MS, exacerbating disability. We retrospectively... multiple sclerosis https://events.diabetes.org/p/s/are-glp-1-receptor-agonists-the-second-hormone-needed-to-treat-pediatric-type-1-diabetes-5523 Are GLP-1 Receptor Agonists the Second Hormone Needed to Treat Pediatric Type 1 Diabetes? -... Disclosures - M.VAN NAME: Consultant; Ended; Novo Nordisk, Soleno Therapeutics, Inc., MannKind Corporation, Research Support; Current; Novo Nordisk, Lilly,... https://noticias.foxnews.com/health/could-weight-loss-medication-isnt-delivering-results GLP-1 receptor gene variant boosts weight-loss drug results, study finds | Fox News GLP-1 weight-loss drugs may work differently depending on genetics, according to a Nature study analyzing data from over 27,000 semaglutide and tirzepatide... https://events.diabetes.org/p/s/what-does-glucagon-receptor-agonism-add-to-the-effects-of-gip-and-glp-1-receptor-agonism-5584 What Does Glucagon Receptor Agonism Add to the Effects of GIP and GLP-1 Receptor Agonism? -... https://pubchem.ncbi.nlm.nih.gov/bioassay/1345918 AID 1345918 - Rat GLP-1 receptor (Glucagon receptor family) - PubChem BioAssay record AID 1345918 submitted by IUPHAR/BPS Guide to PHARMACOLOGY: Rat GLP-1 receptor (Glucagon receptor family). aid rat glp receptor glucagon https://pubmed.ncbi.nlm.nih.gov/41549912/ Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A... Glucagon-like peptide-1 receptor agonists (GLP-1RA) such as semaglutide, liraglutide and tirzepatide are effective for obesity and type 2 diabetes mellitus... nutritional deficiencies associated with https://scholars.uky.edu/en/publications/exploring-the-association-between-suicidal-thoughts-self-injury-a/ Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in... https://events.diabetes.org/p/s/the-combined-use-of-sglt2-inhibitors-and-glp-1-receptor-agonists-on-the-risk-of-cardiovascular-events-among-patients-with-type-2-diabetes-1153 The Combined Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Cardiovascular... https://ascvd-lipidology.knowledgehub.wiley.com/glp-1-receptor-agonists-for-the-reduction-of-atherosclerotic-cardiovascular-risk-in-patients-with-type-2-diabetes/ GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With... https://www.cochrane.org/evidence/CD013650_effects-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibitors-people-cardiovascular-disease The effects of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors for people with... https://events.diabetes.org/p/s/pharmacogenomics-of-glp-1-receptor-agonist-response-in-type-2-diabetes-5675 Pharmacogenomics of GLP-1 Receptor Agonist Response in Type 2 Diabetes - American Diabetes... https://pubmed.ncbi.nlm.nih.gov/36313764/ Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of... Incretin-based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes (T2D). The... https://pubmed.ncbi.nlm.nih.gov/41489846/ Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A... Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A systematic review and Meta-Analysis of randomized controlled... https://ugresearchjournals.illinois.edu/index.php/DHD/article/view/1044/903 View of GLP-1 Receptor Agonists view glp receptor agonists